India's Piramal Pharma up as USFDA inspection ends at US facility

Piramal Pharma (Mumbai)

23/05/2024 07:52

** Shares of Piramal Pharma  PIRM.NS  up 2.7% to 151 rupees
    ** Pharma co said the U.S. FDA issued establishment
inspection report for Lexington, USA-based facility and the
inspection has closed 
    ** Stock on track to log weekly gains of 1.2% after two
straight weeks of losses 
    ** Including session's gains, stock up ~9% YTD 


 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))